Table 1.
Immunosuppressants | CV Risk Factors Exacerbated | |
---|---|---|
Corticosteroids | Prednisone | Hyperglycemia (+++), Arterial hypertension (++), Triglycerides (++), LDL (++). |
Deflazacort | Hyperglycemia (+), Arterial hypertension (++), Triglycerides (+), LDL (+). |
|
Calcineurin Inhibitors | Cyclosporine | Hyperglycemia (+), Arterial hypertension (+++), Triglycerides (++), LDL (+++). |
Tacrolimus | Hyperglycemia (+), Arterial hypertension (+++), Triglycerides (+), LDL (++). |
|
mTOR Inhibitors | Sirolimus | Triglycerides (+++), LDL (+++). |
Everolimus | Triglycerides (+++), LDL (+++). | |
Antiproliferative Agents | Azathioprine | No significant increase |
Mycophenolate Mofetil | No significant increase |
mTOR: mammalian target of rapamycin. (+): mild increase; (++): moderate increase; (+++) severe increase. The magnitude of the effect was arbitrarily estimated by the authors according to the evidence discussed in this review.